<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01823835</url>
  </required_header>
  <id_info>
    <org_study_id>GO29642</org_study_id>
    <secondary_id>2014-004852-77</secondary_id>
    <nct_id>NCT01823835</nct_id>
  </id_info>
  <brief_title>A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer</brief_title>
  <official_title>An Open-Label, Phase Ia/Ib/IIa Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or an LHRH Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genentech, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genentech, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multi-institution, Phase Ia/Ib/IIa open-label, dose-finding, safety,&#xD;
      pharmacokinetics (PK), and proof-of-concept study of GDC-0810 as a single agent and in&#xD;
      combination with palbociclib and/or LHRH agonist. The study is divided into 3 phases: Phase&#xD;
      Ia, Phase Ib, and Phase IIa. During Phase Ia (dose escalation phase), GDC-0810 single agent&#xD;
      will be administered orally on a continuous daily dosing regimen with a Day -7 lead-in period&#xD;
      for single dose PK evaluation prior to the start of daily treatment. The incidence of&#xD;
      dose-limiting toxicities (DLTs) will be evaluated from Day -7 through the first cycle (28&#xD;
      days) of treatment (35 days total). Depending on safety and tolerability, participants will&#xD;
      be assigned sequentially to escalating doses of GDC-0810 using standard 3 + 3 design. During&#xD;
      Phase Ib (dose escalation and expansion phase), participants will receive GDC-0810 with&#xD;
      palbociclib and/or LHRH agonist to determine the recommended Phase II dose (RP2D) and assess&#xD;
      the safety and tolerability of concomitant administration. During Phase IIa (dose expansion&#xD;
      phase), participants previously treated with an aromatase inhibitor (AI) will be treated at&#xD;
      the RP2D to further characterize the safety, PK, pharmacodynamics, and anti-tumor activity of&#xD;
      GDC-0810.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The Sponsor decided to halt the development of GDC-0810, but not due to any safety concerns.&#xD;
  </why_stopped>
  <start_date type="Actual">December 29, 2014</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phase Ia: Maximum Tolerated Dose of GDC-0810 When Used as a Single Agent</measure>
    <time_frame>Day -7 through the first cycle (28 days) of treatment (35 days total)</time_frame>
    <description>Maximum Tolerated Dose (MTD) is determined based on the number of Dose Limiting Toxicities (DLTs) experienced by the participants. DLTs were defined as any of the following adverse events (AEs) that are deemed by the investigator or the Sponsor to be related to study drug (toxicities will be attributed to single agent GDC-0810 unless they are clearly related to disease progression or can clearly be attributed to a cause other than GDC-0810 administration):&#xD;
Any grade ≥ 3 non-hematologic toxicity (excluding alopecia)&#xD;
Any grade ≥ 3 hematologic toxicity of &gt; 7 days' duration&#xD;
Any grade toxicity that leads to study drug interruption of &gt; 7 days' duration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase Ia: RP2D of GDC-0810 When Used as a Single Agent</measure>
    <time_frame>Day -7 through the first cycle (28 days) of treatment (35 days total)</time_frame>
    <description>The recommended Phase II dose (RP2D) was based on the overall safety/tolerability and pharmacokinetic profile of GDC-0810.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase IIa: Percentage of Participants With Confirmed Objective Tumor Response of GDC-0810 According to RECIST v1.1</measure>
    <time_frame>Screening and every 8 weeks from Cycle 1 Day 1 until Cycle 12, thereafter every 3 months until disease progression (up to 3 years)</time_frame>
    <description>Objective response (OR) is defined as a complete response (CR) or partial response (PR) as determined by investigator assessment according to RECIST v1.1. OR was based on criteria related to changes in size of target lesions. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum of diameters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase IIa: Percentage of Participants With Clinical Benefit Response of GDC-0810 According to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)</measure>
    <time_frame>Screening and every 8 weeks from Cycle 1 Day 1 until Cycle 12, thereafter every 3 months until disease progression (up to 3 years)</time_frame>
    <description>Clinical Benefit Response (CBR) is defined as the percentage of participants achieving confirmed RECIST v1.1 defined CR, PR, and/or stable disease. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions. Stable disease was defined as neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase Ib: RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH</measure>
    <time_frame>first cycle (Days 1 to 28 of a 28-day schedule)</time_frame>
    <description>The RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH RP2D was not determined since the development of the GDC-0810 was discontinued before enrolling Cohort C2. The RP2D would have been based on the overall safety and PK/PD profile of GDC-0810 and palbociclib, and not necessarily the MTD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Phases: Percentage of Participants With Adverse Events (AEs)</measure>
    <time_frame>up to 3 years</time_frame>
    <description>An adverse event (AE) is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Maximum Plasma Concentration (Cmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</measure>
    <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, hours postdose</time_frame>
    <description>Maximum Plasma Concentration (Cmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Time to Maximum Concentration (Tmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</measure>
    <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, hours postdose</time_frame>
    <description>Time to Maximum Concentration (Tmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Area Under the Concentration-time Curves at 6 Hours (AUC0-6) of GDC-0810 Single Agent and Its Glucuronide Metabolites</measure>
    <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6 hours postdose</time_frame>
    <description>Area under the concentration-time curves from time 0 to 6 hours (AUC0-6) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Area Under the Concentration-time Curves at 24 Hours (AUC0-24) of GDC-0810 Single Agent and Its Glucuronide Metabolites</measure>
    <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24 hours postdose</time_frame>
    <description>Area under the concentration-time curves from time 0 to 24 hours (AUC0-24) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-Inf)</measure>
    <time_frame>Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, and 48 hours postdose</time_frame>
    <description>Area under the concentration-time curve from time 0-infinity (AUC0-inf) has been calculated using PK samples collected after administration of a single dose (on Day -7) of GDC-0810.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Plasma Half-life (t1/2) of GDC-0810 Single Agent</measure>
    <time_frame>Day -7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose</time_frame>
    <description>Half-life (t1/2) was calculated after single dose administration and not at steady state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ia: Apparent Clearance (Cl/F)</measure>
    <time_frame>Day -7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose</time_frame>
    <description>Apparent Clearance (CL/F) was estimated using PK samples collected following administration of a single dose (on Day -7) of GDC-0810</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase IIa: Effect of GDC-0810 Single Agent on Ventricular Repolarization as Measured by Corrected QT Intervals (QTc) Using Fridericia's Formula</measure>
    <time_frame>Screening; on Cycle 2 Day 1 predose and at 1, 2, 3, 4, and 6 hours postdose; Cycle 3 Day 1 predose, and at 1, 3, and 6 hours post dose</time_frame>
    <description>The corrected QT interval (QTc) was calculated using Fridericia's formula from electrocardiogram (ECG) data. Changes in ECG intervals from baseline were calculated. Triplicate ECG measurements were collected throughout the study. The averaged triplicate ECG measurements were used for analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Cmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</measure>
    <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Tmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</measure>
    <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: AUC0-6 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</measure>
    <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: t/2 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</measure>
    <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Cmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
    <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Tmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
    <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: AUC0-6 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
    <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: t/2 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</measure>
    <time_frame>Cohort C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
    <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Cmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: Tmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: AUC0-6 of LHRH Agonist in Combination With GDC-0810 and/or an Palbociclib</measure>
    <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase Ib: t/2 of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</measure>
    <time_frame>Cohort D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
    <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
  </secondary_outcome>
  <number_of_arms>15</number_of_arms>
  <enrollment type="Actual">152</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 mg GDC-0810 QD in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg GDC-0810 QD in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD in non-fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 7</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>800 mg GDC-0810 QD in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 8</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>800 mg GDC-0810 QD in non-fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ia - Cohort 9</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg GDC-0810 BID in fasting state.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase IIa - Cohort A1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase IIa - Cohort A2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase IIa - Cohort B1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase IIa - Cohort B2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ib - Cohort C1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase Ib - Cohort D1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GDC-0810</intervention_name>
    <description>GDC-0810 administered orally once daily until disease progression, unacceptable toxicity, withdrawal of consent, GDC-0810 drug supply exhausted, or study termination (up to 3 years).</description>
    <arm_group_label>Phase IIa - Cohort A1</arm_group_label>
    <arm_group_label>Phase IIa - Cohort A2</arm_group_label>
    <arm_group_label>Phase IIa - Cohort B1</arm_group_label>
    <arm_group_label>Phase IIa - Cohort B2</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 1</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 2</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 3</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 4</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 5</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 6</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 7</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 8</arm_group_label>
    <arm_group_label>Phase Ia - Cohort 9</arm_group_label>
    <arm_group_label>Phase Ib - Cohort C1</arm_group_label>
    <arm_group_label>Phase Ib - Cohort D1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LHRH Agonist</intervention_name>
    <description>LHRH agonist administered once monthly until disease progression, unacceptable toxicity, withdrawal of consent, GDC-0810 drug supply exhausted, or study termination (up to 3 years). Choice of LHRH agonist will be an institutional choice approved for use in breast cancer.</description>
    <arm_group_label>Phase Ib - Cohort D1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Palbociclib</intervention_name>
    <description>Palbociclib administered orally once daily until disease progression, unacceptable toxicity, withdrawal of consent, GDC-0810 drug supply exhausted, or study termination (up to 3 years).</description>
    <arm_group_label>Phase Ib - Cohort C1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Phase 1a portion&#xD;
&#xD;
          -  Histologically or cytologically proven diagnosis of adenocarcinoma of the breast with&#xD;
             evidence of either locally recurrent disease not amenable to resection or radiation&#xD;
             therapy with curative intent, or metastatic disease, both progressing after at least 6&#xD;
             months of hormonal therapy for estrogen receptor (ER) positive breast cancer&#xD;
&#xD;
          -  ER-positive, human epidermal growth factor 2 (HER2) negative&#xD;
&#xD;
          -  At least 2 months must have elapsed from the use of tamoxifen&#xD;
&#xD;
          -  At least 6 months must have elapsed from the use of fulvestrant&#xD;
&#xD;
          -  At least 2 weeks must have elapsed from the use of any other anticancer hormonal&#xD;
             therapy&#xD;
&#xD;
          -  At least 3 weeks must have elapsed from the use of any chemotherapy&#xD;
&#xD;
          -  Postmenopausal status&#xD;
&#xD;
          -  Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2&#xD;
&#xD;
          -  Adequate organ function&#xD;
&#xD;
        Phase Ib portion&#xD;
&#xD;
          -  All above inclusion criteria, except:&#xD;
&#xD;
          -  Postmenopausal status, pre- and peri-menopausal participants will also be included&#xD;
&#xD;
          -  ECOG performance status less than 2&#xD;
&#xD;
          -  At least 2 months must have elapsed from the use of tamoxifen not applicable&#xD;
&#xD;
          -  At least 6 months must have elapsed from the use of fulvestrant not applicable&#xD;
&#xD;
        and plus:&#xD;
&#xD;
          -  Documented sensitivity to prior hormonal therapy&#xD;
&#xD;
          -  Cohort C1 (palbociclib combination cohorts): no prior treatment with cyclin-dependent&#xD;
             kinase (CDK) 4/6 inhibitor&#xD;
&#xD;
        Phase IIa portion&#xD;
&#xD;
          -  All above inclusion criteria for Phase Ia, except:&#xD;
&#xD;
          -  Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1&#xD;
&#xD;
          -  At least 6 months must have elapsed from the use of fulvestrant not applicable&#xD;
&#xD;
        and plus:&#xD;
&#xD;
          -  Cohort A only: confirmed estrogen receptor alpha (ESR1) mutation and presence of&#xD;
             measurable disease as per RECIST v1.1 or evaluable bone disease&#xD;
&#xD;
          -  Cohort A1 only: no prior fulvestrant allowed; at least 2 months must have elapsed from&#xD;
             the use of tamoxifen&#xD;
&#xD;
          -  Cohort A2 only: prior fulvestrant allowed&#xD;
&#xD;
          -  Cohort B only: disease progression following no more than 1 prior treatment with an&#xD;
             aromatase inhibitor in the advanced/metastatic setting&#xD;
&#xD;
          -  Cohort B1 only: no prior fulvestrant allowed&#xD;
&#xD;
          -  Cohort B2 only: prior fulvestrant allowed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Phase 1a portion&#xD;
&#xD;
          -  Untreated or symptomatic central nervous system (CNS) metastases&#xD;
&#xD;
          -  Endometrial disorders&#xD;
&#xD;
          -  More than 2 prior chemotherapy in the advanced/metastatic setting (prior adjuvant&#xD;
             chemotherapy is allowed so long as it occurred greater than or equal to 12 months&#xD;
             prior to enrollment)&#xD;
&#xD;
          -  Current treatment with any systemic anticancer therapies for advanced disease&#xD;
&#xD;
          -  Any significant cardiac dysfunction within 12 months prior to enrollment&#xD;
&#xD;
          -  Active inflammatory bowel disease or chronic diarrhea, short bowel syndrome, or upper&#xD;
             gastrointestinal surgery including gastric resection&#xD;
&#xD;
          -  Known human immunodeficiency virus (HIV) infection&#xD;
&#xD;
          -  Known clinically significant history of liver disease&#xD;
&#xD;
          -  Major surgery within 4 weeks prior to enrollment&#xD;
&#xD;
          -  Radiation therapy within 2 weeks prior to enrollment&#xD;
&#xD;
        Phase Ib portion - all above exclusion criteria, plus:&#xD;
&#xD;
          -  Cohort C1 (palbociclib combination cohorts): history of venous thromboembolic event&#xD;
             requiring therapeutic anticoagulation; vaginal bleeding within 2 months prior to&#xD;
             enrollment&#xD;
&#xD;
        Phase IIa portion - all above exclusion criteria, plus:&#xD;
&#xD;
          -  Cohort A1, A2, and Cohort B2 only: more than 1 prior chemotherapy in the&#xD;
             advanced/metastatic setting&#xD;
&#xD;
          -  Cohort B1 only: prior chemotherapy in the advanced/metastatic setting&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Hoffmann-La Roche</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ucsd Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8465</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital.</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount SInai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Cancer Care Alliance</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU MEDISCH CENTRUM; Dept. of Medical Oncology</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Integral Oncologico Clara Campal (CIOCC); Dirección Médica</name>
      <address>
        <city>Madrid</city>
        <zip>28050</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 25, 2013</study_first_submitted>
  <study_first_submitted_qc>March 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <results_first_submitted>February 23, 2021</results_first_submitted>
  <results_first_submitted_qc>May 25, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 18, 2021</results_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Palbociclib</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 25, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/35/NCT01823835/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Phase Ia - Cohort 1</title>
          <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
        </group>
        <group group_id="P2">
          <title>Phase Ia - Cohort 2</title>
          <description>200 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="P3">
          <title>Phase Ia - Cohort 3</title>
          <description>400 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="P4">
          <title>Phase Ia - Cohort 4</title>
          <description>600 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="P5">
          <title>Phase Ia - Cohort 5</title>
          <description>600 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="P6">
          <title>Phase Ia - Cohort 6</title>
          <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
        </group>
        <group group_id="P7">
          <title>Phase Ia - Cohort 7</title>
          <description>800 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="P8">
          <title>Phase Ia - Cohort 8</title>
          <description>800 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="P9">
          <title>Phase Ia - Cohort 9</title>
          <description>400 mg GDC-0810 BID in fasting state.</description>
        </group>
        <group group_id="P10">
          <title>Phase IIa - Cohort A1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
        </group>
        <group group_id="P11">
          <title>Phase IIa - Cohort A2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
        </group>
        <group group_id="P12">
          <title>Phase IIa - Cohort B1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
        </group>
        <group group_id="P13">
          <title>Phase IIa - Cohort B2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
        </group>
        <group group_id="P14">
          <title>Phase Ib - Cohort C1</title>
          <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
        </group>
        <group group_id="P15">
          <title>Phase Ib - Cohort D1</title>
          <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="6"/>
                <participants group_id="P6" count="6"/>
                <participants group_id="P7" count="6"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="19"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="53"/>
                <participants group_id="P13" count="19"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="6"/>
                <participants group_id="P6" count="6"/>
                <participants group_id="P7" count="6"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="19"/>
                <participants group_id="P11" count="10"/>
                <participants group_id="P12" count="53"/>
                <participants group_id="P13" count="19"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive Disease</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="6"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="6"/>
                <participants group_id="P7" count="5"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="18"/>
                <participants group_id="P11" count="8"/>
                <participants group_id="P12" count="46"/>
                <participants group_id="P13" count="18"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study Termination</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Phase Ia - Cohort 1</title>
          <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
        </group>
        <group group_id="B2">
          <title>Phase Ia - Cohort 2</title>
          <description>200 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="B3">
          <title>Phase Ia - Cohort 3</title>
          <description>400 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="B4">
          <title>Phase Ia - Cohort 4</title>
          <description>600 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="B5">
          <title>Phase Ia - Cohort 5</title>
          <description>600 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="B6">
          <title>Phase Ia - Cohort 6</title>
          <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
        </group>
        <group group_id="B7">
          <title>Phase Ia - Cohort 7</title>
          <description>800 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="B8">
          <title>Phase Ia - Cohort 8</title>
          <description>800 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="B9">
          <title>Phase Ia - Cohort 9</title>
          <description>400 mg GDC-0810 BID in fasting state.</description>
        </group>
        <group group_id="B10">
          <title>Phase IIa - Cohort A1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
        </group>
        <group group_id="B11">
          <title>Phase IIa - Cohort A2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
        </group>
        <group group_id="B12">
          <title>Phase IIa - Cohort B1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
        </group>
        <group group_id="B13">
          <title>Phase IIa - Cohort B2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
        </group>
        <group group_id="B14">
          <title>Phase Ib - Cohort C1</title>
          <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
        </group>
        <group group_id="B15">
          <title>Phase Ib - Cohort D1</title>
          <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
        </group>
        <group group_id="B16">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="6"/>
            <count group_id="B5" value="6"/>
            <count group_id="B6" value="6"/>
            <count group_id="B7" value="6"/>
            <count group_id="B8" value="3"/>
            <count group_id="B9" value="3"/>
            <count group_id="B10" value="19"/>
            <count group_id="B11" value="10"/>
            <count group_id="B12" value="53"/>
            <count group_id="B13" value="19"/>
            <count group_id="B14" value="4"/>
            <count group_id="B15" value="6"/>
            <count group_id="B16" value="152"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="5.7"/>
                    <measurement group_id="B2" value="63.5" spread="9.6"/>
                    <measurement group_id="B3" value="60.8" spread="6.9"/>
                    <measurement group_id="B4" value="55.3" spread="8.5"/>
                    <measurement group_id="B5" value="69.3" spread="7.2"/>
                    <measurement group_id="B6" value="56.2" spread="12.8"/>
                    <measurement group_id="B7" value="50.5" spread="14.6"/>
                    <measurement group_id="B8" value="58.3" spread="3.5"/>
                    <measurement group_id="B9" value="64.7" spread="4.0"/>
                    <measurement group_id="B10" value="55.4" spread="12.2"/>
                    <measurement group_id="B11" value="63.4" spread="8.9"/>
                    <measurement group_id="B12" value="61.9" spread="9.3"/>
                    <measurement group_id="B13" value="62.6" spread="12.2"/>
                    <measurement group_id="B14" value="58.5" spread="13.1"/>
                    <measurement group_id="B15" value="41.7" spread="8.9"/>
                    <measurement group_id="B16" value="59.8" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="6"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="6"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="19"/>
                    <measurement group_id="B11" value="10"/>
                    <measurement group_id="B12" value="53"/>
                    <measurement group_id="B13" value="19"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="6"/>
                    <measurement group_id="B16" value="152"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <population>Race/Ethnicity was only collected from 151 participants</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="6"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="17"/>
                    <measurement group_id="B11" value="8"/>
                    <measurement group_id="B12" value="46"/>
                    <measurement group_id="B13" value="15"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="5"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Phase Ia: Maximum Tolerated Dose of GDC-0810 When Used as a Single Agent</title>
        <description>Maximum Tolerated Dose (MTD) is determined based on the number of Dose Limiting Toxicities (DLTs) experienced by the participants. DLTs were defined as any of the following adverse events (AEs) that are deemed by the investigator or the Sponsor to be related to study drug (toxicities will be attributed to single agent GDC-0810 unless they are clearly related to disease progression or can clearly be attributed to a cause other than GDC-0810 administration):&#xD;
Any grade ≥ 3 non-hematologic toxicity (excluding alopecia)&#xD;
Any grade ≥ 3 hematologic toxicity of &gt; 7 days' duration&#xD;
Any grade toxicity that leads to study drug interruption of &gt; 7 days' duration</description>
        <time_frame>Day -7 through the first cycle (28 days) of treatment (35 days total)</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - All Cohorts</title>
            <description>GDC-0810 single agent was administered orally on a continuous daily dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Maximum Tolerated Dose of GDC-0810 When Used as a Single Agent</title>
          <description>Maximum Tolerated Dose (MTD) is determined based on the number of Dose Limiting Toxicities (DLTs) experienced by the participants. DLTs were defined as any of the following adverse events (AEs) that are deemed by the investigator or the Sponsor to be related to study drug (toxicities will be attributed to single agent GDC-0810 unless they are clearly related to disease progression or can clearly be attributed to a cause other than GDC-0810 administration):&#xD;
Any grade ≥ 3 non-hematologic toxicity (excluding alopecia)&#xD;
Any grade ≥ 3 hematologic toxicity of &gt; 7 days' duration&#xD;
Any grade toxicity that leads to study drug interruption of &gt; 7 days' duration</description>
          <population>All participants that were enrolled in Phase Ia of the study.</population>
          <units>milligram (mg)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">The MTD could not be determined.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Phase Ia: RP2D of GDC-0810 When Used as a Single Agent</title>
        <description>The recommended Phase II dose (RP2D) was based on the overall safety/tolerability and pharmacokinetic profile of GDC-0810.</description>
        <time_frame>Day -7 through the first cycle (28 days) of treatment (35 days total)</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - All Cohorts</title>
            <description>GDC-0810 single agent was administered orally on a continuous daily dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: RP2D of GDC-0810 When Used as a Single Agent</title>
          <description>The recommended Phase II dose (RP2D) was based on the overall safety/tolerability and pharmacokinetic profile of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study.</population>
          <units>milligram (mg)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Phase IIa: Percentage of Participants With Confirmed Objective Tumor Response of GDC-0810 According to RECIST v1.1</title>
        <description>Objective response (OR) is defined as a complete response (CR) or partial response (PR) as determined by investigator assessment according to RECIST v1.1. OR was based on criteria related to changes in size of target lesions. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum of diameters.</description>
        <time_frame>Screening and every 8 weeks from Cycle 1 Day 1 until Cycle 12, thereafter every 3 months until disease progression (up to 3 years)</time_frame>
        <population>All participants that were enrolled in Phase IIa of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase IIa - Cohort A1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
          </group>
          <group group_id="O2">
            <title>Phase IIa - Cohort A2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
          </group>
          <group group_id="O3">
            <title>Phase IIa - Cohort B1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
          </group>
          <group group_id="O4">
            <title>Phase IIa - Cohort B2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase IIa: Percentage of Participants With Confirmed Objective Tumor Response of GDC-0810 According to RECIST v1.1</title>
          <description>Objective response (OR) is defined as a complete response (CR) or partial response (PR) as determined by investigator assessment according to RECIST v1.1. OR was based on criteria related to changes in size of target lesions. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum of diameters.</description>
          <population>All participants that were enrolled in Phase IIa of the study.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="53"/>
                <count group_id="O4" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Complete Response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Partial Response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="7.5"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Phase IIa: Percentage of Participants With Clinical Benefit Response of GDC-0810 According to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)</title>
        <description>Clinical Benefit Response (CBR) is defined as the percentage of participants achieving confirmed RECIST v1.1 defined CR, PR, and/or stable disease. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions. Stable disease was defined as neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease.</description>
        <time_frame>Screening and every 8 weeks from Cycle 1 Day 1 until Cycle 12, thereafter every 3 months until disease progression (up to 3 years)</time_frame>
        <population>All participants that were enrolled in Phase IIa of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase IIa - Cohort A1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
          </group>
          <group group_id="O2">
            <title>Phase IIa - Cohort A2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
          </group>
          <group group_id="O3">
            <title>Phase IIa - Cohort B1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
          </group>
          <group group_id="O4">
            <title>Phase IIa - Cohort B2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase IIa: Percentage of Participants With Clinical Benefit Response of GDC-0810 According to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1)</title>
          <description>Clinical Benefit Response (CBR) is defined as the percentage of participants achieving confirmed RECIST v1.1 defined CR, PR, and/or stable disease. CR was the disappearance of all target lesions. PR was defined as at least a 30% decrease in the sum of diameters of target lesions. Stable disease was defined as neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for progressive disease.</description>
          <population>All participants that were enrolled in Phase IIa of the study.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="53"/>
                <count group_id="O4" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3"/>
                    <measurement group_id="O2" value="10.0"/>
                    <measurement group_id="O3" value="28.3"/>
                    <measurement group_id="O4" value="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Phase Ib: RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH</title>
        <description>The RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH RP2D was not determined since the development of the GDC-0810 was discontinued before enrolling Cohort C2. The RP2D would have been based on the overall safety and PK/PD profile of GDC-0810 and palbociclib, and not necessarily the MTD.</description>
        <time_frame>first cycle (Days 1 to 28 of a 28-day schedule)</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH</title>
          <description>The RP2D of GDC-0810 When Used in Combination With Palbociclib and/or LHRH RP2D was not determined since the development of the GDC-0810 was discontinued before enrolling Cohort C2. The RP2D would have been based on the overall safety and PK/PD profile of GDC-0810 and palbociclib, and not necessarily the MTD.</description>
          <population>All participants that were enrolled in Phase Ib of the study.</population>
          <units>mg</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Due to discontinuation of GDC-0810 development, data is limited and RP2D was not determined</measurement>
                    <measurement group_id="O2" value="NA">Due to discontinuation of GDC-0810 development, data is limited and RP2D was not determined</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Phases: Percentage of Participants With Adverse Events (AEs)</title>
        <description>An adverse event (AE) is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment.</description>
        <time_frame>up to 3 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
          <group group_id="O10">
            <title>Phase IIa - Cohort A1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
          </group>
          <group group_id="O11">
            <title>Phase IIa - Cohort A2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
          </group>
          <group group_id="O12">
            <title>Phase IIa - Cohort B1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
          </group>
          <group group_id="O13">
            <title>Phase IIa - Cohort B2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
          </group>
          <group group_id="O14">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O15">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>All Phases: Percentage of Participants With Adverse Events (AEs)</title>
          <description>An adverse event (AE) is any untoward medical occurrence in a participant or clinical investigation participant administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="19"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="53"/>
                <count group_id="O13" value="19"/>
                <count group_id="O14" value="4"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="100"/>
                    <measurement group_id="O4" value="100"/>
                    <measurement group_id="O5" value="100"/>
                    <measurement group_id="O6" value="100"/>
                    <measurement group_id="O7" value="100"/>
                    <measurement group_id="O8" value="100"/>
                    <measurement group_id="O9" value="100"/>
                    <measurement group_id="O10" value="100"/>
                    <measurement group_id="O11" value="100"/>
                    <measurement group_id="O12" value="100"/>
                    <measurement group_id="O13" value="100"/>
                    <measurement group_id="O14" value="100"/>
                    <measurement group_id="O15" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Maximum Plasma Concentration (Cmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
        <description>Maximum Plasma Concentration (Cmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
        <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Maximum Plasma Concentration (Cmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
          <description>Maximum Plasma Concentration (Cmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>micrograms per milliliter (ug/mL)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GDC-0810 (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.29" spread="1.24"/>
                    <measurement group_id="O2" value="3.76" spread="0.599"/>
                    <measurement group_id="O3" value="9.4" spread="2.53"/>
                    <measurement group_id="O4" value="12.7" spread="5.36"/>
                    <measurement group_id="O5" value="22.2" spread="11.6"/>
                    <measurement group_id="O6" value="9.73" spread="4.5"/>
                    <measurement group_id="O7" value="15.9" spread="3.13"/>
                    <measurement group_id="O8" value="15.6" spread="4.97"/>
                    <measurement group_id="O9" value="10.1" spread="4.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810 (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.59" spread="1.43"/>
                    <measurement group_id="O2" value="3.26" spread="1.11"/>
                    <measurement group_id="O3" value="9.08" spread="3.43"/>
                    <measurement group_id="O4" value="11.8" spread="6.61"/>
                    <measurement group_id="O5" value="25" spread="8.35"/>
                    <measurement group_id="O6" value="8.89" spread="3.96"/>
                    <measurement group_id="O7" value="18.4" spread="4.84"/>
                    <measurement group_id="O8" value="25.5" spread="9.3"/>
                    <measurement group_id="O9" value="13.9" spread="4.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0171" spread="0.021"/>
                    <measurement group_id="O2" value="0.0535" spread="0.015"/>
                    <measurement group_id="O3" value="0.177" spread="0.1"/>
                    <measurement group_id="O4" value="0.468" spread="0.388"/>
                    <measurement group_id="O5" value="0.691" spread="0.526"/>
                    <measurement group_id="O6" value="0.299" spread="0.171"/>
                    <measurement group_id="O7" value="1.38" spread="1.19"/>
                    <measurement group_id="O8" value="0.369" spread="0.338"/>
                    <measurement group_id="O9" value="0.153" spread="0.0421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.067" spread="0.055"/>
                    <measurement group_id="O2" value="0.061" spread="0.0271"/>
                    <measurement group_id="O3" value="0.184" spread="0.0832"/>
                    <measurement group_id="O4" value="0.416" spread="0.346"/>
                    <measurement group_id="O5" value="0.723" spread="0.338"/>
                    <measurement group_id="O6" value="0.181" spread="0.0846"/>
                    <measurement group_id="O7" value="0.74" spread="0.327"/>
                    <measurement group_id="O8" value="1.17" spread="0.893"/>
                    <measurement group_id="O9" value="0.308" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="1.46" spread="0.997"/>
                    <measurement group_id="O4" value="3" spread="0.827"/>
                    <measurement group_id="O5" value="2.26" spread="1.24"/>
                    <measurement group_id="O6" value="1.35" spread="0.876"/>
                    <measurement group_id="O7" value="7.02" spread="8.19"/>
                    <measurement group_id="O8" value="1.29" spread="0.617"/>
                    <measurement group_id="O9" value="1.36" spread="0.421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="1.89" spread="1.34"/>
                    <measurement group_id="O4" value="3.64" spread="2.96"/>
                    <measurement group_id="O5" value="3.16" spread="1.2"/>
                    <measurement group_id="O6" value="0.993" spread="0.435"/>
                    <measurement group_id="O7" value="3.37" spread="2.34"/>
                    <measurement group_id="O8" value="4.62" spread="2.19"/>
                    <measurement group_id="O9" value="2.82" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Time to Maximum Concentration (Tmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
        <description>Time to Maximum Concentration (Tmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
        <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Time to Maximum Concentration (Tmax) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
          <description>Time to Maximum Concentration (Tmax) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>hour (hr)</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GDC-0810 (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" lower_limit="1.5" upper_limit="2"/>
                    <measurement group_id="O2" value="1.71" lower_limit="1.45" upper_limit="2"/>
                    <measurement group_id="O3" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O4" value="2.99" lower_limit="1.25" upper_limit="4"/>
                    <measurement group_id="O5" value="3.01" lower_limit="1.5" upper_limit="6"/>
                    <measurement group_id="O6" value="1.48" lower_limit="0.217" upper_limit="3.03"/>
                    <measurement group_id="O7" value="3.04" lower_limit="2.17" upper_limit="4"/>
                    <measurement group_id="O8" value="2" lower_limit="2" upper_limit="4.07"/>
                    <measurement group_id="O9" value="1.88" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810 (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.47" lower_limit="0.95" upper_limit="2"/>
                    <measurement group_id="O2" value="0.9" lower_limit="0.45" upper_limit="1"/>
                    <measurement group_id="O3" value="1.55" lower_limit="1.07" upper_limit="1.68"/>
                    <measurement group_id="O4" value="2.48" lower_limit="1.93" upper_limit="6.45"/>
                    <measurement group_id="O5" value="2.95" lower_limit="1.95" upper_limit="4.03"/>
                    <measurement group_id="O6" value="1.65" lower_limit="0.917" upper_limit="3.07"/>
                    <measurement group_id="O7" value="1.59" lower_limit="1.08" upper_limit="1.92"/>
                    <measurement group_id="O8" value="2.93" lower_limit="1.53" upper_limit="6.3"/>
                    <measurement group_id="O9" value="2.05" lower_limit="1.47" upper_limit="2.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" lower_limit="0.5" upper_limit="1.5"/>
                    <measurement group_id="O2" value="1.95" lower_limit="1.5" upper_limit="2"/>
                    <measurement group_id="O3" value="2" lower_limit="1.52" upper_limit="3"/>
                    <measurement group_id="O4" value="2.85" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="O5" value="3.51" lower_limit="1.5" upper_limit="6.07"/>
                    <measurement group_id="O6" value="1.72" lower_limit="0.217" upper_limit="3.03"/>
                    <measurement group_id="O7" value="3.54" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O8" value="3" lower_limit="2" upper_limit="4.07"/>
                    <measurement group_id="O9" value="1.88" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2.05"/>
                    <measurement group_id="O2" value="1" lower_limit="0.9" upper_limit="1.48"/>
                    <measurement group_id="O3" value="1.64" lower_limit="1.52" upper_limit="2.08"/>
                    <measurement group_id="O4" value="3.49" lower_limit="1.93" upper_limit="4.45"/>
                    <measurement group_id="O5" value="2.95" lower_limit="1.95" upper_limit="4.03"/>
                    <measurement group_id="O6" value="1.65" lower_limit="0.917" upper_limit="3.07"/>
                    <measurement group_id="O7" value="2.27" lower_limit="1.08" upper_limit="3.03"/>
                    <measurement group_id="O8" value="2.93" lower_limit="1.53" upper_limit="6.3"/>
                    <measurement group_id="O9" value="2.05" lower_limit="1.47" upper_limit="3.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="2" lower_limit="1.52" upper_limit="3"/>
                    <measurement group_id="O4" value="2.85" lower_limit="2.72" upper_limit="2.98"/>
                    <measurement group_id="O5" value="3.51" lower_limit="2" upper_limit="6.07"/>
                    <measurement group_id="O6" value="1.98" lower_limit="0.717" upper_limit="3.03"/>
                    <measurement group_id="O7" value="3.54" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O8" value="3" lower_limit="2" upper_limit="4.07"/>
                    <measurement group_id="O9" value="2.98" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="1.84" lower_limit="1.52" upper_limit="2.17"/>
                    <measurement group_id="O4" value="3.53" lower_limit="3.07" upper_limit="4"/>
                    <measurement group_id="O5" value="2.95" lower_limit="1.95" upper_limit="4.03"/>
                    <measurement group_id="O6" value="1.65" lower_limit="0.917" upper_limit="3.07"/>
                    <measurement group_id="O7" value="2.27" lower_limit="1.08" upper_limit="3.03"/>
                    <measurement group_id="O8" value="2.93" lower_limit="1.53" upper_limit="6.3"/>
                    <measurement group_id="O9" value="2.05" lower_limit="2" upper_limit="3.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Area Under the Concentration-time Curves at 6 Hours (AUC0-6) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
        <description>Area under the concentration-time curves from time 0 to 6 hours (AUC0-6) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
        <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6 hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Area Under the Concentration-time Curves at 6 Hours (AUC0-6) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
          <description>Area under the concentration-time curves from time 0 to 6 hours (AUC0-6) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>hr*ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GDC-0810 (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" spread="1.65"/>
                    <measurement group_id="O2" value="6.78" spread="1.19"/>
                    <measurement group_id="O3" value="23.7" spread="11.3"/>
                    <measurement group_id="O4" value="34.3" spread="14.4"/>
                    <measurement group_id="O5" value="58.2" spread="28.9"/>
                    <measurement group_id="O6" value="18.8" spread="7.38"/>
                    <measurement group_id="O7" value="51.1" spread="18"/>
                    <measurement group_id="O8" value="48.3" spread="28.4"/>
                    <measurement group_id="O9" value="22.1" spread="5.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810 (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.83" spread="2.3"/>
                    <measurement group_id="O2" value="6.19" spread="2.18"/>
                    <measurement group_id="O3" value="18.8" spread="4.76"/>
                    <measurement group_id="O4" value="41.1" spread="27.5"/>
                    <measurement group_id="O5" value="74.9" spread="30.1"/>
                    <measurement group_id="O6" value="19.3" spread="7.01"/>
                    <measurement group_id="O7" value="65.7" spread="20.6"/>
                    <measurement group_id="O8" value="70.5" spread="22"/>
                    <measurement group_id="O9" value="43" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0401" spread="0.0197"/>
                    <measurement group_id="O2" value="0.116" spread="0.0729"/>
                    <measurement group_id="O3" value="0.321" spread="0.149"/>
                    <measurement group_id="O4" value="1.16" spread="0.815"/>
                    <measurement group_id="O5" value="1.36" spread="0.917"/>
                    <measurement group_id="O6" value="0.486" spread="0.36"/>
                    <measurement group_id="O7" value="3.81" spread="4.15"/>
                    <measurement group_id="O8" value="0.938" spread="0.983"/>
                    <measurement group_id="O9" value="0.29" spread="0.0295"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.105" spread="0.0724"/>
                    <measurement group_id="O2" value="0.103" spread="0.0335"/>
                    <measurement group_id="O3" value="0.321" spread="0.105"/>
                    <measurement group_id="O4" value="1.37" spread="1.21"/>
                    <measurement group_id="O5" value="1.83" spread="1.01"/>
                    <measurement group_id="O6" value="0.409" spread="0.23"/>
                    <measurement group_id="O7" value="2.63" spread="1.01"/>
                    <measurement group_id="O8" value="2.08" spread="1.15"/>
                    <measurement group_id="O9" value="0.974" spread="0.605"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="3.18" spread="1.77"/>
                    <measurement group_id="O4" value="8.25" spread="4.54"/>
                    <measurement group_id="O5" value="5.29" spread="2.71"/>
                    <measurement group_id="O6" value="2.76" spread="2.23"/>
                    <measurement group_id="O7" value="21.1" spread="26.9"/>
                    <measurement group_id="O8" value="3.99" spread="2.29"/>
                    <measurement group_id="O9" value="3.27" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="3.72" spread="1.91"/>
                    <measurement group_id="O4" value="13" spread="11.1"/>
                    <measurement group_id="O5" value="8.25" spread="3.47"/>
                    <measurement group_id="O6" value="2.03" spread="0.669"/>
                    <measurement group_id="O7" value="14" spread="11.1"/>
                    <measurement group_id="O8" value="10.2" spread="3.61"/>
                    <measurement group_id="O9" value="8.45" spread="5.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Area Under the Concentration-time Curves at 24 Hours (AUC0-24) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
        <description>Area under the concentration-time curves from time 0 to 24 hours (AUC0-24) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
        <time_frame>Single Dose: Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24 hours postdose; Multiple Doses: Day 29 (Cycle 2 Day 1) at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24 hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Area Under the Concentration-time Curves at 24 Hours (AUC0-24) of GDC-0810 Single Agent and Its Glucuronide Metabolites</title>
          <description>Area under the concentration-time curves from time 0 to 24 hours (AUC0-24) has been calculated using PK samples collected after administration of a single dose (on Day -7) and also following once-daily multiple doses (at steady state on Day 29) of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>hr*ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="6"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GDC-0810 (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="1.75"/>
                    <measurement group_id="O2" value="8.81" spread="2.52"/>
                    <measurement group_id="O3" value="28.5" spread="15.6"/>
                    <measurement group_id="O4" value="44.7" spread="19.5"/>
                    <measurement group_id="O5" value="101" spread="49.9"/>
                    <measurement group_id="O6" value="41.2" spread="15.9"/>
                    <measurement group_id="O7" value="61.8" spread="25.5"/>
                    <measurement group_id="O8" value="95.1" spread="76.4"/>
                    <measurement group_id="O9" value="47.7" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810 (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.34" spread="2.99"/>
                    <measurement group_id="O2" value="7.36" spread="1.32"/>
                    <measurement group_id="O3" value="22.8" spread="6.14"/>
                    <measurement group_id="O4" value="66.9" spread="46.8"/>
                    <measurement group_id="O5" value="102" spread="35.9"/>
                    <measurement group_id="O6" value="44.2" spread="14.5"/>
                    <measurement group_id="O7" value="80.4" spread="26.8"/>
                    <measurement group_id="O8" value="75.2" spread="15.4"/>
                    <measurement group_id="O9" value="109" spread="73.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.0197"/>
                    <measurement group_id="O2" value="0.224" spread="0.109"/>
                    <measurement group_id="O3" value="0.413" spread="0.152"/>
                    <measurement group_id="O4" value="1.54" spread="1.08"/>
                    <measurement group_id="O5" value="2.08" spread="1.02"/>
                    <measurement group_id="O6" value="1.07" spread="0.786"/>
                    <measurement group_id="O7" value="5.67" spread="7.17"/>
                    <measurement group_id="O8" value="1.83" spread="2.04"/>
                    <measurement group_id="O9" value="0.649" spread="0.055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-N-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="5"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.0141"/>
                    <measurement group_id="O2" value="0.132" spread="0.0253"/>
                    <measurement group_id="O3" value="0.413" spread="0.121"/>
                    <measurement group_id="O4" value="2.63" spread="2.21"/>
                    <measurement group_id="O5" value="2.64" spread="1.4"/>
                    <measurement group_id="O6" value="1.09" spread="0.594"/>
                    <measurement group_id="O7" value="3.72" spread="1.81"/>
                    <measurement group_id="O8" value="2.35" spread="1.57"/>
                    <measurement group_id="O9" value="2.66" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Single Dose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="2"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="4"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="3.76" spread="2.13"/>
                    <measurement group_id="O4" value="11.4" spread="7.43"/>
                    <measurement group_id="O5" value="8.59" spread="3.82"/>
                    <measurement group_id="O6" value="6.03" spread="4.89"/>
                    <measurement group_id="O7" value="30.6" spread="44"/>
                    <measurement group_id="O8" value="7.64" spread="5.51"/>
                    <measurement group_id="O9" value="7.1" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GDC-0810-Acyl-Glucuronide (Multiple Doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="4"/>
                    <count group_id="O4" value="6"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="5"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="2"/>
                    <count group_id="O9" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O3" value="4.42" spread="2.27"/>
                    <measurement group_id="O4" value="21.8" spread="21.2"/>
                    <measurement group_id="O5" value="10.4" spread="4.07"/>
                    <measurement group_id="O6" value="4.61" spread="1.34"/>
                    <measurement group_id="O7" value="18.1" spread="16.3"/>
                    <measurement group_id="O8" value="12" spread="5.44"/>
                    <measurement group_id="O9" value="20.8" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-Inf)</title>
        <description>Area under the concentration-time curve from time 0-infinity (AUC0-inf) has been calculated using PK samples collected after administration of a single dose (on Day -7) of GDC-0810.</description>
        <time_frame>Day-7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, and 48 hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study, provided sufficient blood samples for analysis and received once daily dosing.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-Time Curve From Time 0 to Infinity (AUC0-Inf)</title>
          <description>Area under the concentration-time curve from time 0-infinity (AUC0-inf) has been calculated using PK samples collected after administration of a single dose (on Day -7) of GDC-0810.</description>
          <population>All participants that were enrolled in Phase Ia of the study, provided sufficient blood samples for analysis and received once daily dosing.</population>
          <units>hr*ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="5"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="4"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="1.96"/>
                    <measurement group_id="O2" value="10" spread="2.8"/>
                    <measurement group_id="O3" value="30.8" spread="16.3"/>
                    <measurement group_id="O4" value="40.5" spread="11.3"/>
                    <measurement group_id="O5" value="114" spread="57.4"/>
                    <measurement group_id="O7" value="65.7" spread="28"/>
                    <measurement group_id="O8" value="101" spread="78.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Plasma Half-life (t1/2) of GDC-0810 Single Agent</title>
        <description>Half-life (t1/2) was calculated after single dose administration and not at steady state.</description>
        <time_frame>Day -7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Plasma Half-life (t1/2) of GDC-0810 Single Agent</title>
          <description>Half-life (t1/2) was calculated after single dose administration and not at steady state.</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>hr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="5"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="4"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.7" spread="3.47"/>
                    <measurement group_id="O2" value="15.2" spread="2.35"/>
                    <measurement group_id="O3" value="24.1" spread="17.3"/>
                    <measurement group_id="O4" value="9.58" spread="3.41"/>
                    <measurement group_id="O5" value="7.91" spread="2.67"/>
                    <measurement group_id="O6" value="NA" spread="NA">t1/2 can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. With twice-daily dosing (BID), the PK samples were collected for only up to 6 hours following a dose (after which the patients received their next dose), which is not sufficient to estimate t1/2. Therefore, t1/2 was not reported for BID cohorts.</measurement>
                    <measurement group_id="O7" value="10.1" spread="1.59"/>
                    <measurement group_id="O8" value="7.09" spread="3.23"/>
                    <measurement group_id="O9" value="NA" spread="NA">t1/2 can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. With twice-daily dosing (BID), the PK samples were collected for only up to 6 hours following a dose (after which the patients received their next dose), which is not sufficient to estimate t1/2. Therefore, t1/2 was not reported for BID cohorts.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ia: Apparent Clearance (Cl/F)</title>
        <description>Apparent Clearance (CL/F) was estimated using PK samples collected following administration of a single dose (on Day -7) of GDC-0810</description>
        <time_frame>Day -7 at 0 (predose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 24, 48 hours postdose</time_frame>
        <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ia - Cohort 1</title>
            <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ia - Cohort 2</title>
            <description>200 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O3">
            <title>Phase Ia - Cohort 3</title>
            <description>400 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O4">
            <title>Phase Ia - Cohort 4</title>
            <description>600 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O5">
            <title>Phase Ia - Cohort 5</title>
            <description>600 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O6">
            <title>Phase Ia - Cohort 6</title>
            <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
          </group>
          <group group_id="O7">
            <title>Phase Ia - Cohort 7</title>
            <description>800 mg GDC-0810 QD in fasting state.</description>
          </group>
          <group group_id="O8">
            <title>Phase Ia - Cohort 8</title>
            <description>800 mg GDC-0810 QD in non-fasting state.</description>
          </group>
          <group group_id="O9">
            <title>Phase Ia - Cohort 9</title>
            <description>400 mg GDC-0810 BID in fasting state.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ia: Apparent Clearance (Cl/F)</title>
          <description>Apparent Clearance (CL/F) was estimated using PK samples collected following administration of a single dose (on Day -7) of GDC-0810</description>
          <population>All participants that were enrolled in Phase Ia of the study and provided sufficient blood samples for analysis.</population>
          <units>L/hr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="5"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="4"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.4" spread="6.43"/>
                    <measurement group_id="O2" value="21" spread="4.94"/>
                    <measurement group_id="O3" value="15.1" spread="5.56"/>
                    <measurement group_id="O4" value="15.7" spread="4.13"/>
                    <measurement group_id="O5" value="8.21" spread="8.38"/>
                    <measurement group_id="O6" value="NA" spread="NA">CL/F can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. With BID dosing, the PK samples were collected for only up to 6 hours before the patient received their next dose, which is not sufficient to estimated CL/F. Therefore, CL/F was not reported for BID cohorts.</measurement>
                    <measurement group_id="O7" value="15.1" spread="9.45"/>
                    <measurement group_id="O8" value="11.1" spread="6.23"/>
                    <measurement group_id="O9" value="NA" spread="NA">CL/F can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. With BID dosing, the PK samples were collected for only up to 6 hours before the patient received their next dose, which is not sufficient to estimated CL/F. Therefore, CL/F was not reported for BID cohorts.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase IIa: Effect of GDC-0810 Single Agent on Ventricular Repolarization as Measured by Corrected QT Intervals (QTc) Using Fridericia's Formula</title>
        <description>The corrected QT interval (QTc) was calculated using Fridericia's formula from electrocardiogram (ECG) data. Changes in ECG intervals from baseline were calculated. Triplicate ECG measurements were collected throughout the study. The averaged triplicate ECG measurements were used for analysis.</description>
        <time_frame>Screening; on Cycle 2 Day 1 predose and at 1, 2, 3, 4, and 6 hours postdose; Cycle 3 Day 1 predose, and at 1, 3, and 6 hours post dose</time_frame>
        <population>All participants enrolled in Phase IIa of the study and with post baseline ECG measurements</population>
        <group_list>
          <group group_id="O1">
            <title>Phase IIa - Cohort A1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
          </group>
          <group group_id="O2">
            <title>Phase IIa - Cohort A2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
          </group>
          <group group_id="O3">
            <title>Phase IIa - Cohort B1</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
          </group>
          <group group_id="O4">
            <title>Phase IIa - Cohort B2</title>
            <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase IIa: Effect of GDC-0810 Single Agent on Ventricular Repolarization as Measured by Corrected QT Intervals (QTc) Using Fridericia's Formula</title>
          <description>The corrected QT interval (QTc) was calculated using Fridericia's formula from electrocardiogram (ECG) data. Changes in ECG intervals from baseline were calculated. Triplicate ECG measurements were collected throughout the study. The averaged triplicate ECG measurements were used for analysis.</description>
          <population>All participants enrolled in Phase IIa of the study and with post baseline ECG measurements</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>≤ 450 milliseconds (msec)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="66.7"/>
                    <measurement group_id="O3" value="91.2"/>
                    <measurement group_id="O4" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;450 and ≤480 msec</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="34"/>
                    <count group_id="O4" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="33.3"/>
                    <measurement group_id="O3" value="8.8"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increase from baseline ≤30 msec</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="33"/>
                    <count group_id="O4" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="93.9"/>
                    <measurement group_id="O4" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increase from baseline &gt;30 and ≤60 msec</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="33"/>
                    <count group_id="O4" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6.1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Cmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
        <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Cmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
          <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study and provided sufficient samples for analysis.</population>
          <units>ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1 (C1D1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="2.98"/>
                    <measurement group_id="O2" value="8.96" spread="1.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 8 (C1D8)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.95" spread="5.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 2 Day 1 (C2D1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="9.62" spread="0.0354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Tmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
        <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Tmax of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
          <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study and provided sufficient samples for analysis.</population>
          <units>hr</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" lower_limit="1" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3" lower_limit="3" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: AUC0-6 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
        <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: AUC0-6 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
          <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study.</population>
          <units>hr*ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.9" spread="9.19"/>
                    <measurement group_id="O2" value="33.6" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.2" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="38.8" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: t/2 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
        <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
        <time_frame>C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8; D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>No data from any participants could be used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
          <group group_id="O2">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: t/2 of GDC-0810 in Combination With Palbociclib and/or an LHRH Agonist</title>
          <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
          <population>No data from any participants could be used for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Cmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
        <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Cmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
          <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
          <units>ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.8" spread="9.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" spread="27.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Tmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
        <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Tmax of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
          <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
          <units>hr</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="3" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="0" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: AUC0-6 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
        <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: AUC0-6 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
          <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort C1 and provided sufficient samples for analysis.</population>
          <units>hr*ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200" spread="41.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="464" spread="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: t/2 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
        <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
        <time_frame>Cohort C1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 1 Day 8</time_frame>
        <population>No data from any participants could be used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort C1</title>
            <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: t/2 of Palbociclib in Combination With GDC-0810 and/or an LHRH Agonist</title>
          <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
          <population>No data from any participants could be used for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Cmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
        <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Cmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
          <description>Cmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
          <units>ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.6" spread="9.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.4" spread="NA">The Standard Deviation is not applicable as the results data are reported for 1 participant only.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: Tmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
        <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: Tmax of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
          <description>Tmax has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
          <units>hr</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C1D8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="NA" upper_limit="NA">The Range is not applicable as the results data are reported for 1 participant only.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: AUC0-6 of LHRH Agonist in Combination With GDC-0810 and/or an Palbociclib</title>
        <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
        <time_frame>Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: AUC0-6 of LHRH Agonist in Combination With GDC-0810 and/or an Palbociclib</title>
          <description>AUC0-6 has been calculated using PK samples collected after GDC-0810 administration.</description>
          <population>All participants that were enrolled in Phase Ib of the study, Cohort D1 and provided sufficient samples for analysis.</population>
          <units>hr*ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>C1D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118" spread="76.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C2D1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="106" spread="NA">The Standard Deviation is not applicable as the results data are reported for 1 participant only.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phase Ib: t/2 of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
        <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
        <time_frame>Cohort D1: Predose and at 1, 2, 3, 4, and 6 hours postdose on Cycle 1 Day 1 and Cycle 2 Day 1</time_frame>
        <population>No data from any participants could be used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Phase Ib - Cohort D1</title>
            <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
          </group>
        </group_list>
        <measure>
          <title>Phase Ib: t/2 of LHRH Agonist in Combination With GDC-0810 and/or Palbociclib</title>
          <description>Half-life (t1/2) can be estimated only when the PK sample collection following a dose is long enough to characterize the elimination phase. The PK samples in these cohorts were only collected up to 6 hours following the dose, hence, t1/2 could not be estimated.</description>
          <population>No data from any participants could be used for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 3 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Phase Ia - Cohort 1</title>
          <description>100 mg GDC-0810 once daily (QD) in fasting state.</description>
        </group>
        <group group_id="E2">
          <title>Phase Ia - Cohort 2</title>
          <description>200 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="E3">
          <title>Phase Ia - Cohort 3</title>
          <description>400 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="E4">
          <title>Phase Ia - Cohort 4</title>
          <description>600 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="E5">
          <title>Phase Ia - Cohort 5</title>
          <description>600 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="E6">
          <title>Phase Ia - Cohort 6</title>
          <description>300 mg GDC-0810 twice daily (BID) in fasting state.</description>
        </group>
        <group group_id="E7">
          <title>Phase Ia - Cohort 7</title>
          <description>800 mg GDC-0810 QD in fasting state.</description>
        </group>
        <group group_id="E8">
          <title>Phase Ia - Cohort 8</title>
          <description>800 mg GDC-0810 QD in non-fasting state.</description>
        </group>
        <group group_id="E9">
          <title>Phase Ia - Cohort 9</title>
          <description>400 mg GDC-0810 BID in fasting state.</description>
        </group>
        <group group_id="E10">
          <title>Phase IIa - Cohort A1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had confirmed ER-a (ESR1) mutation of the ligand binding domain (LBD).</description>
        </group>
        <group group_id="E11">
          <title>Phase IIa - Cohort A2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and confirmed ER-a (ESR1) mutation of the LBD.</description>
        </group>
        <group group_id="E12">
          <title>Phase IIa - Cohort B1</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm did not receive any prior treatment with fulvestrant and had progressed following ≤1 prior therapy with an aromatase inhibitor (AI).</description>
        </group>
        <group group_id="E13">
          <title>Phase IIa - Cohort B2</title>
          <description>600 mg GDC-0810 QD. Additionally, participants in this arm had prior treatment with fulvestrant and progressed following ≤1 prior therapy with an AI.</description>
        </group>
        <group group_id="E14">
          <title>Phase Ib - Cohort C1</title>
          <description>400 mg GDC-0810 + 125 mg Palbociclib QD.</description>
        </group>
        <group group_id="E15">
          <title>Phase Ib - Cohort D1</title>
          <description>≤600 mg GDC-0810 QD + LHRH agonist once monthly.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA version 23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="11" subjects_at_risk="53"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>ADRENAL INSUFFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>DISEASE PROGRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>HEPATIC HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>APPENDICITIS PERFORATED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SKIN INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD BILIRUBIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TUMOUR PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SEIZURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>DEVICE DISLOCATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>ENDOMETRIAL HYPERPLASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VENOUS THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA version 23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="18" subjects_at_risk="19"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E12" subjects_affected="51" subjects_at_risk="53"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="19"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E5" events="13" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="6" subjects_affected="6" subjects_at_risk="53"/>
                <counts group_id="E13" events="8" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LYMPHOPENIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NEUTROPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="5" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="4" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BRADYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SINUS TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PERICARDIAL EFFUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SINUS BRADYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>EAR PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>EXTERNAL EAR PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TINNITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>BLEPHARITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DRY EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>EYELID PTOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VISION BLURRED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>IDIOPATHIC ORBITAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LACRIMATION INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PHOTOPSIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL DISCOMFORT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="11" subjects_affected="10" subjects_at_risk="53"/>
                <counts group_id="E13" events="3" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="11" subjects_affected="6" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E4" events="7" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="5" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="21" subjects_affected="16" subjects_at_risk="53"/>
                <counts group_id="E13" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="11" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E4" events="6" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E5" events="22" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E6" events="12" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E7" events="21" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E8" events="7" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" events="6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E10" events="16" subjects_affected="10" subjects_at_risk="19"/>
                <counts group_id="E11" events="11" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E12" events="66" subjects_affected="28" subjects_at_risk="53"/>
                <counts group_id="E13" events="30" subjects_affected="11" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="13" subjects_affected="6" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DRY MOUTH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="5" subjects_affected="5" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="8" subjects_affected="6" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="6" subjects_affected="6" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="6" subjects_affected="6" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ERUCTATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="14" subjects_affected="13" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="10" subjects_affected="9" subjects_at_risk="53"/>
                <counts group_id="E13" events="5" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="11" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E7" events="15" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" events="7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="9" subjects_affected="8" subjects_at_risk="19"/>
                <counts group_id="E11" events="6" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E12" events="32" subjects_affected="24" subjects_at_risk="53"/>
                <counts group_id="E13" events="10" subjects_affected="9" subjects_at_risk="19"/>
                <counts group_id="E14" events="6" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E15" events="8" subjects_affected="4" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>STOMATITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="15" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E8" events="5" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="11" subjects_affected="7" subjects_at_risk="19"/>
                <counts group_id="E11" events="5" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E12" events="22" subjects_affected="14" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="5" subjects_affected="3" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FAECES SOFT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GINGIVAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GINGIVAL SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LIP SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ORAL MUCOSAL ERUPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CHILLS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E4" events="7" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E5" events="6" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="12" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E8" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" events="7" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E10" events="9" subjects_affected="8" subjects_at_risk="19"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="29" subjects_affected="27" subjects_at_risk="53"/>
                <counts group_id="E13" events="7" subjects_affected="7" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GAIT DISTURBANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>IMPAIRED HEALING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUCOSAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SWELLING FACE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TENDERNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FACIAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LOCALISED INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ORAL HERPES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SKIN INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TOOTH INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="9" subjects_affected="8" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VAGINAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VULVOVAGINAL MYCOTIC INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BREAST CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CROUP INFECTIOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>EYE INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FUNGAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FURUNCLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS NOROVIRUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GINGIVITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HELICOBACTER INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ORAL CANDIDIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OTITIS EXTERNA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VIRAL UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CONTUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PELVIC FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ARTHROPOD BITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAND FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCLE STRAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PROCEDURAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RIB FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SKIN LACERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WOUND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>ALANINE AMINOTRANSFERASE INCREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="8" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E5" events="5" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="6" subjects_affected="5" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ASPARTATE AMINOTRANSFERASE INCREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="6" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E6" events="7" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD ALKALINE PHOSPHATASE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD URIC ACID INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMOGLOBIN DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LIVER FUNCTION TEST INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TRANSAMINASES INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="4" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WEIGHT INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELL COUNT DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="10" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>AMYLASE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BILIRUBIN CONJUGATED INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD ALKALINE PHOSPHATASE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD BILIRUBIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD CHLORIDE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD CHOLESTEROL INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="6" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD LACTATE DEHYDROGENASE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD PHOSPHORUS INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD THYROID STIMULATING HORMONE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLOOD URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>CRYSTAL URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GLUCOSE URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HIGH DENSITY LIPOPROTEIN DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HIGH DENSITY LIPOPROTEIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LOW DENSITY LIPOPROTEIN INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="5" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LYMPHOCYTE COUNT DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NEUTROPHIL COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="5" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NEUTROPHIL COUNT INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NITRITE URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PLATELET COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RED BLOOD CELL COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RED BLOOD CELLS URINE POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY CASTS PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELL COUNT INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="6" subjects_affected="6" subjects_at_risk="19"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E12" events="9" subjects_affected="9" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERTRIGLYCERIDAEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="5" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOALBUMINAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOMAGNESAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOPHOSPHATAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERMAGNESAEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERPROTEINAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERURICAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="6" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOCHLORAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="5" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="5" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="18" subjects_affected="14" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="15" subjects_affected="13" subjects_at_risk="53"/>
                <counts group_id="E13" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BONE PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FLANK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCLE SPASMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="4" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="7" subjects_affected="7" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL STIFFNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NECK MASS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OSTEONECROSIS OF JAW</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="6" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PAIN IN JAW</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SPINAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>GROIN PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>JOINT STIFFNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>METASTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF SKIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ATAXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSGEUSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="12" subjects_affected="9" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERSOMNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MEMORY IMPAIRMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NEUROPATHY PERIPHERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PARAESTHESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="6" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PERIPHERAL SENSORY NEUROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>TASTE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VOCAL CORD PARALYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LETHARGY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SCIATICA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>INSOMNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MOOD SWINGS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SUICIDAL IDEATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>IRRITABILITY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MOOD ALTERED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE KIDNEY INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MICTURITION URGENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY TRACT PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PROTEINURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RENAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URINARY TRACT DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BREAST ATROPHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BREAST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ENDOMETRIAL THICKENING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OEDEMA GENITAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PELVIC PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VAGINAL DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="9" subjects_affected="9" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="9" subjects_affected="8" subjects_at_risk="53"/>
                <counts group_id="E13" events="4" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSPAREUNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>UTERINE POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VAGINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>VULVOVAGINAL DRYNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="11" subjects_affected="8" subjects_at_risk="53"/>
                <counts group_id="E13" events="6" subjects_affected="5" subjects_at_risk="19"/>
                <counts group_id="E14" events="4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DRY THROAT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>NASAL CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>OROPHARYNGEAL PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PRODUCTIVE COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>UPPER-AIRWAY COUGH SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>WHEEZING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPOXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RHINORRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ALOPECIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>BLISTER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DERMATITIS ACNEIFORM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>DRY SKIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ERYTHEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERHIDROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PAPULE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PRURITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="53"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RASH MACULO-PAPULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>SKIN ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>URTICARIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ACNE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>ERYTHEMA MULTIFORME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LICHEN SCLEROSUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MACULE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>MADAROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PAIN OF SKIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>RASH ERYTHEMATOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>FLUSHING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HOT FLUSH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E6" events="6" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="7" subjects_affected="7" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="11" subjects_affected="10" subjects_at_risk="53"/>
                <counts group_id="E13" events="9" subjects_affected="9" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="5" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="53"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>PALLOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>LYMPHOEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Communications</name_or_title>
      <organization>Hoffmann-La Roche</organization>
      <phone>800 821-8590</phone>
      <email>genentech@druginfo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

